Senior European Union officials on Wednesday decided to block CK Hutchison Holding’s multibillion-dollar purchase of Telefónica’s British mobile operator O2, reported the Wall Street Journal.
The decision will pave the way for a formal signoff on the decision by the bloc’s 28 commissioners expected next week, the people said.
Senior technical experts meet to hash out final points of contention among the commission’s various departments before final approval is sought. Once there is a consensus at this level, it is rare for commissioners to overturn it.
The EU has until May 19 to make a final decision on the deal.
The companies had offered commitments to help waive the deal through, but ultimately the remedies couldn’t mollify the EU antitrust regulator’s concerns the merger would lead to higher prices and less choice for UK consumers.
The imminent EU decision represents a tougher attitude by EU regulators toward consolidation among telecom companies in the region, particularly in cases in which the number of operators in a given country shrinks from four to three, as would have been the case with CK Hutchison’s UK deal.
The deal would have joined Hong Kong-based CK Hutchison’s Three U.K., the country’s fourth-largest operator, with Telefónica SA’s O2, the UK’s second-largest mobile operator.
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas